Searched for
NAPROXEN SODIUM TABLETS
Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%Budget 2026 underlines the government’s intent – in terms of the sectors it will focus on. Now, it is not all of a sudden that the governme...
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...
- Key to big wealth creation: ‘Hold’ quality stocks for long. 16 stocks which fit the bill with an upside potential of up to 44%You know what B2B is? Yes, it is “Business to Business”. But stock market veterans use it in a different way. They use B2B to describe a ce...
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...
- Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Drug makers Glenmark, Aurobindo recall products in USGlenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartr...
- Drug makers Granules India, Jubilant Cadista recall products in US marketSalisbury-based Jubilant Cadista Pharmaceuticals Inc is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of Noida-based Ju...
- Stocks in the news: SBI, Airtel, DRL, Tata Consumer and Adani Group stocksSBI, Titan, Adani Green, Godrej Consumer, Adani Gas, ICICI Lombard GIC, Bosch, Tata Communications, Hindustan Petroleum, OFSS and Apollo Ty...
- Granules India gets USFDA nod for sleep aid drugThe US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramin...
- Aurobindo Pharma shares end with 3% gains on USFDA nodShares of Aurobindo Pharma ended with 3 per cent gains today after the company got final approval from the USFDA to manufacture and market ...
- Aurobindo Pharma climbs after USFDA nod for OTC drugThe stock soared 2.31 per cent to Rs 738 on BSE. On NSE too, shares of the company climbed 2.31 per cent to Rs 737.95.
- TRACK SENSEX, NIFTY LIVE: Who moved my market todayIf you are reading this, chances are Sensex and Nifty are part of your daily life, and actions on Dalal Street can make or mar your day.
- Twelve stocks in focus in Monday morning tradeThe Indian market is expected to open flat. Here is a list of top twelve stocks that are likely to be in focus today.
- Aurobindo Pharma gets USFDA nod for osteoporosis drug"The approved product has an estimated market size of USD 96 million for the twelve months ended January 2016 according to IMS," it said.
- Glenmark gets USFDA approval for anti-cholesterol drugGlenmark Pharmaceuticals Ltd has received US FDA (United States Food and Drug Administration) approval for an anti-cholesterol drug Pravast...
Load More
